Does diabetes mellitus target motor neurons?

Neurobiology of Disease

Volumn 26, Issue 2, 2007, Pages 301-311

  Ramji, Noor ^a   Toth, Cory ^a   Kennedy, James ^a   Zochodne, Douglas W ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Diabetic neuropathy; Motor axons; Motor neurons; Motor units; Neuromuscular junction; Polyneuropathy

Indexed keywords

STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FATE; CELL FUNCTION; CELL SURVIVAL; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; HUMAN; HUMAN CELL; LUMBAR SPINAL CORD; MOTOR UNIT POTENTIAL; MOUSE; NERVE CELL NETWORK; NERVE CONDUCTION; NERVE ENDING; NERVE FIBER DEGENERATION; NEUROMUSCULAR SYNAPSE; NEUROPROTECTION; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SENSORY NERVE CELL; SPINAL CORD MOTONEURON; STREPTOZOCIN DIABETES;

ANIMALS; AXONS; CELL SURVIVAL; CYTOPROTECTION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HEAT-SHOCK PROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MOTOR NEURON DISEASE; MOTOR NEURONS; NEURAL CONDUCTION; NEUROMUSCULAR JUNCTION; PERIPHERAL NERVES; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-AKT; STRESS; UP-REGULATION; WALLERIAN DEGENERATION;

EID: 34147164608     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.11.016     Document Type: Article

References (52)

1. Andersen H. Motor function in diabetic neuropathy. Acta Neurol. Scand. 100 (1999) 211-220
2. Andersen H., Gjerstad M.D., and Jakobsen J. Atrophy of foot muscles: a measure of diabetic neuropathy. Diabetes Care 27 (2004) 2382-2385
3. Arvidson B. Distribution of protein tracers in peripheral ganglia. A light and electron microscopic study in rodents after various modes of tracer administration. Acta Univ. Ups. 344 (1979) 1-72
4. Boulton A.J., and Ward J.D. Diabetic neuropathies and pain. Clin. Endocrinol. Metab. 15 (1986) 917-931
5. Bruey J.M., Ducasse C., Bonniaud P., Ravagnan L., Susin S.A., az-Latoud C., Gurbuxani S., Arrigo A.P., Kroemer G., Solary E., and Garrido C. Hsp27 negatively regulates cell death by interacting with cytochrome c 1. Nat. Cell Biol. 2 (2000) 645-652
6. Bus S.A., Yang Q.X., Wang J.H., Smith M.B., Wunderlich R., and Cavanagh P.R. Intrinsic muscle atrophy and toe deformity in the diabetic neuropathic foot: a magnetic resonance imaging study. Diabetes Care 25 (2002) 1444-1450
7. Cai F., and Helke C.J. Abnormal PI3 kinase/Akt signal pathway in vagal afferent neurons and vagus nerve of streptozotocin-diabetic rats. Brain Res. Mol. Brain Res. 110 (2003) 234-244
8. Carper S.W., Rocheleau T.A., Cimino D., and Storm F.K. Heat shock protein 27 stimulates recovery of RNA and protein synthesis following a heat shock. J. Cell. Biochem. 66 (1997) 153-164
9. Cheng C., and Zochodne D.W. Sensory neurons with activated caspase-3 survive long-term experimental diabetes. Diabetes 52 (2003) 2363-2371
10. Coggeshall R.E., and Lekan H.A. Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J. Comp. Neurol. 364 (1996) 6-15
11. Cross T.G., Scheel-Toellner D., Henriquez N.V., Deacon E., Salmon M., and Lord J.M. Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 256 (2000) 34-41
12. Fahim M.A., el-Sabban F., and Davidson N. Muscle contractility decrement and correlated morphology during the pathogenesis of streptozotocin-diabetic mice. Anat. Rec. 251 (1998) 240-244
13. Fahim M.A., Hasan M.Y., and Alshuaib W.B. Early morphological remodeling of neuromuscular junction in a murine model of diabetes. J. Appl. Physiol. 89 (2000) 2235-2240
14. Gordon T., Sulaiman O., and Boyd J.G. Experimental strategies to promote functional recovery after peripheral nerve injuries. J. Peripher. Nerv. Syst. 8 (2003) 236-250
15. Greene D.A., Lattimer S., Ulbrecht J., and Carroll P. Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy. Diabetes Care 8 (1985) 290-299
16. Grimby G., Einarsson G., Hedberg M., and Aniansson A. Muscle adaptive changes in post-polio subjects. Scand. J. Rehabil. Med. 21 (1989) 19-26
17. Ha H.C., and Snyder S.H. Poly(ADP-ribose) polymerase-1 in the nervous system. Neurobiol. Dis. 7 (2000) 225-239
18. Hansen S., and Ballantyne J.P. Axonal dysfunction in the neuropathy of diabetes mellitus: a quantitative electrophysiological study. J. Neurol. Neurosurg. Psychiatry 40 (1977) 555-564
19. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., Nagashima M., Lundh E.R., Vijay S., and Nitecki D. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270 (1995) 25752-25761
20. Jakob U., Gaestel M., Engel K., and Buchner J. Small heat shock proteins are molecular chaperones. J. Biol. Chem. 268 (1993) 1517-1520
21. Janssen J.A., and Lamberts S.W. Circulating IGF-I and its protective role in the pathogenesis of diabetic angiopathy. Clin. Endocrinol. (Oxf.) 52 (2000) 1-9
22. Kennedy J.M., and Zochodne D.W. The regenerative deficit of peripheral nerves in experimental diabetes: its extent, timing and possible mechanisms. Brain 123 (2000) 2118-2129
23. Kennedy J.M., and Zochodne D.W. Experimental diabetic neuropathy and spontaneous recovery: is there irreparable damage?. Diabetes 54 (2005) 830-837
24. Kikkawa Y., Kuwabara S., Misawa S., Tamura N., Kitano Y., Ogawara K., and Hattori T. The acute effects of glycemic control on nerve conduction in human diabetics. Clin. Neurophysiol. 116 (2005) 270-274
25. Lecker S.H., Jagoe R.T., Gilbert A., Gomes M., Baracos V., Bailey J., Price S.R., Mitch W.E., and Goldberg A.L. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 18 (2004) 39-51
26. Marques M.J., and Santo Neto H. Acetylcholine receptors and nerve terminal distribution at the neuromuscular junction of non-obese diabetic mice. Anat. Rec. 267 (2002) 112-119
27. Messi M.L., and Delbono O. Target-derived trophic effect on skeletal muscle innervation in senescent mice. J. Neurosci. 23 (2003) 1351-1359
28. Murashov A.K., Ul Haq I., Hill C., Park E., Smith M., Wang X., Goldberg D.J., and Wolgemuth D.J. Crosstalk between p38, Hsp25 and Akt in spinal motor neurons after sciatic nerve injury. Brain Res. Mol. Brain Res. 93 (2001) 199-208
29. Namikawa K., Honma M., Abe K., Takeda M., Mansur K., Obata T., Miwa A., Okado H., and Kiyama H. Akt/protein kinase B prevents injury-induced motoneuron death and accelerates axonal regeneration. J. Neurosci. 20 (2000) 2875-2886
30. Obrosova I.G., Li F., Abatan O.I., Forsell M.A., Komjati K., Pacher P., Szabo C., and Stevens M.J. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes 53 (2004) 711-720
31. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Re 29 (2001) e45
32. Purves D., Augustine G.J.F.D., Katz L.C., LaMantia A., McNamara J.O., and Williams S.M. Neuroscience (2001), Sinauer Associates, Inc., Sunderland MA
33. Rogalla T., Ehrnsperger M., Preville X., Kotlyarov A., Lutsch G., Ducasse C., Paul C., Wieske M., Arrigo A.P., Buchner J., and Gaestel M. Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation. J. Biol. Chem. 274 (1999) 18947-18956
34. Sasaki H., Schmelzer J.D., Zollman P.J., and Low P.A. Neuropathology and blood flow of nerve, spinal roots and dorsal root ganglia in longstanding diabetic rats. Acta Neuropathol. 93 (1997) 118-128
35. Schmeichel A.M., Schmelzer J.D., and Low P.A. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 52 (2003) 165-171
36. Schmidt A.M., Hori O., Cao R., Yan S.D., Brett J., Wautier J.L., Ogawa S., Kuwabara K., Matsumoto M., and Stern D. RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 45 Suppl. 3 (1996) S77-S80
37. Shefner J.M. Motor unit number estimation in human neurological diseases and animal models. Clin. Neurophysiol. 112 (2001) 955-964
38. Shefner J.M., Cudkowicz M.E., and Brown Jr. R.H. Comparison of incremental with multipoint MUNE methods in transgenic ALS mice. Muscle Nerve 25 (2002) 39-42
39. Sima A.A. New insights into the metabolic and molecular basis for diabetic neuropathy. Cell. Mol. Life Sci. 60 (2003) 2445-2464
40. Sima A.A.F., Brismar T., and Yagihashi S. Neuropathies encountered in the spontaneously diabetic BB Wistar rat. In: Dyck P.J., Thomas P.K., Asbury A.K., Winegrad A.I., and Porte Jr. D. (Eds). Diabetic Neuropathy (1987), W.B. Saunders, Toronto
41. Stern D., Yan S.D., Yan S.F., and Schmidt A.M. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv. Drug Delivery Rev. 54 (2002) 1615-1625
42. Stern D.M., Yan S.D., Yan S.F., and Schmidt A.M. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes. Ageing Res. Rev. 1 (2002) 1-15
43. Tam S.L., and Gordon T. Mechanisms controlling axonal sprouting at the neuromuscular junction. J.Neurocytol. 32 (2003) 961-974
44. Toth C., Brussee V., Cheng C., and Zochodne D.W. Diabetes mellitus and the sensory neuron. J. Neuropathol. Exp. Neurol. 63 (2004) 561-573
45. Trojan D.A., Gendron D., and Cashman N.R. Electrophysiology and electrodiagnosis of the post-polio motor unit. Orthopedics 14 (1991) 1353-1361
46. Tuck R.R., Schmelzer J.D., and Low P.A. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107 (1984) 935-950
47. Vincent A.M., Mobley B.C., Hiller A., and Feldman E.L. IGF-I prevents glutamate-induced motor neuron programmed cell death. Neurobiol. Dis. 16 (2004) 407-416
48. Vlassara H. The AGE-receptor in the pathogenesis of diabetic complications. Diabetes Metab. Res. Rev. 17 (2001) 436-443
49. Vlassara H., and Palace M.R. Diabetes and advanced glycation endproducts. J. Intern. Med. 251 (2002) 87-101
50. Yagihashi S. Pathogenetic mechanisms of diabetic neuropathy: lessons from animal models. J. Peripher. Nerv. Syst. 2 (1997) 113-132
51. Zochodne D.W., and Ho L.T. The influence of indomethacin and guanethidine on experimental streptozotocin diabetic neuropathy. Can. J. Neurol. Sci. 19 (1992) 433-441
52. Zochodne D.W., Verge V.M.K., Cheng C., Sun H., and Johnston J. Does diabetes target ganglion neurons? Progressive sensory neuron involvement in long term experimental diabetes. Brain 124 (2001) 2319-2334